176 related articles for article (PubMed ID: 27930879)
1. Melanoma exosomes deliver a complex biological payload that upregulates PTPN11 to suppress T lymphocyte function.
Wu Y; Deng W; McGinley EC; Klinke DJ
Pigment Cell Melanoma Res; 2017 Mar; 30(2):203-218. PubMed ID: 27930879
[TBL] [Abstract][Full Text] [Related]
2. Exosomes derived from B16F0 melanoma cells alter the transcriptome of cytotoxic T cells that impacts mitochondrial respiration.
Bland CL; Byrne-Hoffman CN; Fernandez A; Rellick SL; Deng W; Klinke DJ
FEBS J; 2018 Mar; 285(6):1033-1050. PubMed ID: 29399967
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cell-derived exosomes need to activate both T and B cells to induce antitumor immunity.
Näslund TI; Gehrmann U; Qazi KR; Karlsson MC; Gabrielsson S
J Immunol; 2013 Mar; 190(6):2712-9. PubMed ID: 23418627
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.
Xie Y; Bai O; Zhang H; Li W; Xiang J
Cancer Biother Radiopharm; 2010 Feb; 25(1):21-8. PubMed ID: 20187793
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity.
Xie Y; Zhang H; Li W; Deng Y; Munegowda MA; Chibbar R; Qureshi M; Xiang J
J Immunol; 2010 Nov; 185(9):5268-78. PubMed ID: 20881190
[TBL] [Abstract][Full Text] [Related]
6. Synergistic induction of adaptive antitumor immunity by codelivery of antigen with α-galactosylceramide on exosomes.
Gehrmann U; Hiltbrunner S; Georgoudaki AM; Karlsson MC; Näslund TI; Gabrielsson S
Cancer Res; 2013 Jul; 73(13):3865-76. PubMed ID: 23658368
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of cytolytic CD8+ T cells in B16-melanoma and proliferation of mature T cells in TIS21-knockout mice after T cell receptor stimulation.
Ryu MS; Woo MY; Kwon D; Hong AE; Song KY; Park S; Lim IK
Exp Cell Res; 2014 Oct; 327(2):209-21. PubMed ID: 25088256
[TBL] [Abstract][Full Text] [Related]
8. Role of Lymphocyte Subsets in the Immune Response to Primary B Cell-Derived Exosomes.
Saunderson SC; McLellan AD
J Immunol; 2017 Oct; 199(7):2225-2235. PubMed ID: 28842467
[TBL] [Abstract][Full Text] [Related]
9. Activated T cell exosomes promote tumor invasion via Fas signaling pathway.
Cai Z; Yang F; Yu L; Yu Z; Jiang L; Wang Q; Yang Y; Wang L; Cao X; Wang J
J Immunol; 2012 Jun; 188(12):5954-61. PubMed ID: 22573809
[TBL] [Abstract][Full Text] [Related]
10. Novel T-cell-based vaccines via arming polyclonal CD4
Xu A; Freywald A; Xiang J
Immunotherapy; 2016 Nov; 8(11):1265-1269. PubMed ID: 27993084
[No Abstract] [Full Text] [Related]
11. Macrophages play an essential role in antigen-specific immune suppression mediated by T CD8⁺ cell-derived exosomes.
Nazimek K; Ptak W; Nowak B; Ptak M; Askenase PW; Bryniarski K
Immunology; 2015 Sep; 146(1):23-32. PubMed ID: 25808106
[TBL] [Abstract][Full Text] [Related]
12. Enhanced suppression of polyclonal CD8
Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs in Tumor Exosomes Drive Immune Escape in Melanoma.
Vignard V; Labbé M; Marec N; André-Grégoire G; Jouand N; Fonteneau JF; Labarrière N; Fradin D
Cancer Immunol Res; 2020 Feb; 8(2):255-267. PubMed ID: 31857348
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cell-derived exosomes stimulate stronger CD8+ CTL responses and antitumor immunity than tumor cell-derived exosomes.
Hao S; Bai O; Yuan J; Qureshi M; Xiang J
Cell Mol Immunol; 2006 Jun; 3(3):205-11. PubMed ID: 16893501
[TBL] [Abstract][Full Text] [Related]
15. Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment.
Cekic C; Day YJ; Sag D; Linden J
Cancer Res; 2014 Dec; 74(24):7250-9. PubMed ID: 25377469
[TBL] [Abstract][Full Text] [Related]
16. Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude mice.
Wang L; Xie Y; Ahmed KA; Ahmed S; Sami A; Chibbar R; Xu Q; Kane SE; Hao S; Mulligan SJ; Xiang J
Breast Cancer Res Treat; 2013 Jul; 140(2):273-84. PubMed ID: 23881522
[TBL] [Abstract][Full Text] [Related]
17. Exosomes from M1-Polarized Macrophages Potentiate the Cancer Vaccine by Creating a Pro-inflammatory Microenvironment in the Lymph Node.
Cheng L; Wang Y; Huang L
Mol Ther; 2017 Jul; 25(7):1665-1675. PubMed ID: 28284981
[TBL] [Abstract][Full Text] [Related]
18. Melanoma cell-derived exosomes in plasma of melanoma patients suppress functions of immune effector cells.
Sharma P; Diergaarde B; Ferrone S; Kirkwood JM; Whiteside TL
Sci Rep; 2020 Jan; 10(1):92. PubMed ID: 31919420
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Unrelated CD4 T Cell Help Augments CD134 plus CD137 Dual Costimulation Tumor Therapy.
Mittal P; St Rose MC; Wang X; Ryan JM; Wasser JS; Vella AT; Adler AJ
J Immunol; 2015 Dec; 195(12):5816-26. PubMed ID: 26561553
[TBL] [Abstract][Full Text] [Related]
20. Exosomal cancer immunotherapy is independent of MHC molecules on exosomes.
Hiltbrunner S; Larssen P; Eldh M; Martinez-Bravo MJ; Wagner AK; Karlsson MC; Gabrielsson S
Oncotarget; 2016 Jun; 7(25):38707-38717. PubMed ID: 27231849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
